RIGHTEST iFree2 CGM — Designed for Trust, Sustainability, and Ease of Use

Bionime Corporation

Taichung, Taiwan

Bionime focuses on diabetes care and developed the first domestically approved RIGHTEST iFree Continuous Glucose Monitoring System (CGM) . Unlike traditional finger-prick testing, iFree CGM uses a soft sensor inserted under the skin and works with a dedicated app to continuously track glucose for 15 days, allowing users and caregivers to monitor changes in real time while reducing the discomfort of frequent pricks. Bionime has also implemented over 2,000 quality control procedures and established an Industry 4.0 automated production line, ensuring stable manufacturing and high reliability. Guided by its mission to provide high-quality, affordable CGMs, Bionime strives to make CGM widely accessible and fulfill its vision: Better Health for More People .